You are searching for: hsa04919

---

T16792 Target Info	Target Name	Iodothyronine deiodinase type I (DIO1)
	Target type	Successful Target
	Disease	Hyperthyroidism;
	Drugs	Propylthiouracil	Drug Info

T35940 Target Info	Target Name	ERK activator kinase 1 (MEK1)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T70977 Target Info	Target Name	Glycogen synthase kinase-3 beta (GSK-3B)
	Target type	Clinical trial Target
	Disease	Myotonic dystrophy; Acute myeloid leukaemia;
	Drugs	AMO-02	Drug Info

T51191 Target Info	Target Name	Histone deacetylase 2 (HDAC2)
	Target type	Clinical trial Target
	Disease	Lymphoma; Dermatitis;
	Drugs	CHR-3996	Drug Info

T67619 Target Info	Target Name	RAC-alpha serine/threonine-protein kinase (AKT1)
	Target type	Successful Target
	Disease	Triple negative breast cancer; Colorectal cancer;
	Drugs	Capivasertib	Drug Info

T89055 Target Info	Target Name	ERK activator kinase 2 (MEK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T58970 Target Info	Target Name	Extracellular signal-regulated kinase 2 (ERK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T71266 Target Info	Target Name	RAC-gamma serine/threonine-protein kinase (AKT3)
	Target type	Successful Target
	Disease	Breast cancer; Triple negative breast cancer;
	Drugs	Capivasertib	Drug Info

T00176 Target Info	Target Name	Ubiquitin-protein ligase E3 Mdm2 (MDM2)
	Target type	Clinical trial Target
	Disease	Haematological malignancy; Prolymphocytic leukaemia;
	Drugs	RG7388	Drug Info

T15739 Target Info	Target Name	Cellular tumor antigen p53 (TP53)
	Target type	Clinical trial Target
	Disease	Renal transplantation; Polycystic ovarian syndrome;
	Drugs	Contusugene ladenovec	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.